Skip to main content
. 2007 Apr 27;334(7601):987. doi: 10.1136/bmj.39166.597836.BE

Table 3.

 Cognitive function at each cognitive assessment

Cognitive test (assessment) Aspirin group Placebo group Mean difference* (95% CI)
No of participants Adjusted mean (SE) No of participants Adjusted mean (SE)
Global score†:
 First 3215 −0.01 (0.01) 3162 0.00 (0.01) −0.01 (−0.04 to 0.02)
 Second 2873 0.07 (0.01) 2819 0.06 (0.01) 0.01 (−0.03 to 0.04)
 Third 2630 0.02 (0.01) 2596 0.02 (0.01) 0.00 (−0.04 to 0.04)
Verbal memory score‡:
 First 3215 −0.01 (0.01) 3162 0.01 (0.01) −0.02 (−0.05 to 0.02)
 Second 2873 0.13 (0.01) 2819 0.13 (0.01) 0.00 (−0.04 to 0.04)
 Third 2630 0.09 (0.02) 2596 0.11 (0.02) −0.02 (−0.06 to 0.02)
TICS test:
 First 3208 34.18 (0.05) 3154 34.26 (0.05) −0.08 (−0.22 to 0.05)
 Second 2871 34.07 (0.05) 2817 34.12 (0.05) −0.05 (−0.20 to 0.10)
 Third 2630 34.09 (0.06) 2596 34.11 (0.06) −0.02 (−0.19 to 0.14)
Category fluency test:
 First 3202 17.58 (0.09) 3151 17.46 (0.09) 0.12 (−0.13 to 0.36)
 Second 2871 18.13 (0.10) 2817 18.02 (0.10) 0.12 (−0.15 to 0.39)
 Third 2629 17.76 (0.10) 2596 17.38 (0.10) 0.37 (0.10 to 0.65)

TICS=telephone interview of cognitive status.

*From longitudinal linear models by treatment assignment of mean cognitive performance.

†Composite of five tests: TICS, immediate and delayed recalls of east Boston memory test, delayed recall of 10 word list, and category fluency.

‡Composite of four tests: immediate and delayed recalls of both 10 word list and east Boston memory test.